Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.

Weinberg A, Spritzler J, Nokta M, Schrier R, Landay A, Brown D, Pollard R; ACTG CMV Task Force.

Clin Vaccine Immunol. 2008 Sep;15(9):1398-409. doi: 10.1128/CVI.00479-07. Epub 2008 Jun 25.

3.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

PMID:
11443550
4.
5.

[Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].

Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.

Mikrobiyol Bul. 2016 Apr;50(2):224-35. Turkish.

6.

Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.

De Castro N, Carmagnat M, Kernéis S, Scieux C, Rabian C, Molina JM.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1089-97. doi: 10.1089/AID.2010.0340. Epub 2011 May 4.

PMID:
21417759
7.

Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART.

Weinberg A, Wiznia AA, Lafleur BJ, Shah S, Levin MJ.

AIDS Res Hum Retroviruses. 2006 Mar;22(3):283-8.

PMID:
16545015
8.
9.

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.

Aichelburg MC, Weseslindtner L, Mandorfer M, Strassl R, Rieger A, Reiberger T, Puchhammer-Stöckl E, Grabmeier-Pfistershammer K.

PLoS One. 2015 Aug 31;10(8):e0137096. doi: 10.1371/journal.pone.0137096. eCollection 2015.

10.

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.

Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.

J Infect Dis. 2005 Mar 15;191(6):873-80. Epub 2005 Jan 31.

PMID:
15717261
11.

Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients.

Weinberg A, Wohl DA, Brown DG, Pott GB, Zhang L, Ray MG, van der Horst C.

J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):109-14.

PMID:
11103040
12.
13.
15.
16.

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.

Keane NM, Price P, Stone SF, John M, Murray RJ, French MA.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1991-6.

PMID:
11153082
17.

Functional impairment of CMV-reactive cellular immunity during pregnancy.

Reuschel E, Barabas S, Zeman F, Bendfeldt H, Rascle A, Deml L, Seelbach-Goebel B.

J Med Virol. 2017 Feb;89(2):324-331. doi: 10.1002/jmv.24639. Epub 2016 Sep 7.

PMID:
27447923
18.

Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.

Alatrakchi N, Damond F, Matheron S, Beretta-Tempelhoff S, Campa P, Carcelain G, Brun-Vezinet F, Autran B; French HIV-2 study group.

AIDS. 2006 Jan 2;20(1):29-34.

PMID:
16327316
19.

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.

Abate D, Saldan A, Forner G, Tinto D, Bianchin A, Palù G.

J Virol Methods. 2014 Feb;196:157-62. doi: 10.1016/j.jviromet.2013.10.036. Epub 2013 Nov 8.

PMID:
24216234

Supplemental Content

Support Center